Raymond James Financial Initiates Coverage on Astera Labs (NASDAQ:ALAB)

Research analysts at Raymond James Financial assumed coverage on shares of Astera Labs (NASDAQ:ALAB) in a note issued to investors on Friday, Marketbeat Ratings reports. The firm set a “hold” rating on the stock.

A number of other equities research analysts have also weighed in on ALAB. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, October 8th. BNP Paribas initiated coverage on Astera Labs in a research note on Thursday. They issued an “outperform” rating for the company. Evercore ISI raised their target price on Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, August 6th. Morgan Stanley upped their price target on Astera Labs from $200.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Finally, Cowen reissued a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus target price of $187.06.

Astera Labs Trading Up 1.8%

NASDAQ ALAB opened at $141.80 on Friday. The company has a market cap of $23.95 billion, a P/E ratio of 127.75, a PEG ratio of 2.64 and a beta of 1.37. The company has a fifty day simple moving average of $185.11 and a 200 day simple moving average of $146.27. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. During the same quarter in the prior year, the company posted $0.23 earnings per share. The business’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Sell-side analysts predict that Astera Labs will post 0.34 EPS for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 4,620 shares of the company’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $668,467.80. Following the completion of the transaction, the general counsel owned 147,040 shares in the company, valued at $21,275,217.60. This represents a 3.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Sanjay Gajendra sold 90,459 shares of the firm’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief operating officer directly owned 1,599,750 shares of the company’s stock, valued at approximately $231,467,827.50. This represents a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 619,436 shares of company stock valued at $96,530,060 in the last ninety days. Insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Several institutional investors have recently added to or reduced their stakes in ALAB. Assetmark Inc. raised its position in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after acquiring an additional 101 shares during the period. Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Astera Labs during the 2nd quarter worth approximately $29,000. Bernard Wealth Management Corp. bought a new stake in shares of Astera Labs in the 2nd quarter worth approximately $36,000. National Bank of Canada FI lifted its stake in Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares during the last quarter. Finally, Wexford Capital LP bought a new position in Astera Labs during the third quarter valued at $39,000. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.